| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 03/03/2005 | US20050049213 Method for preventing or reversing asthma and compositions useful therefor |
| 03/03/2005 | US20050048609 Fluorescent protein for use as diagnostic indicator in transformed plant or fish cells; biosensors |
| 03/03/2005 | US20050048528 Using immunoglobulins and diagnostic and/or prognostic tool for detection and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy |
| 03/03/2005 | US20050048053 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications |
| 03/03/2005 | US20050048044 Controlling, adjustment diffusion or degradation of membrane using activating energy source such as light source or ultraviolet radiation |
| 03/03/2005 | US20050047999 Matrix metalloproteinase inhibitors |
| 03/03/2005 | US20050047997 Method for the evaluation of the efficiency of a therapeutic action upon the human organism |
| 03/03/2005 | DE10335192A1 Medical implant for animal or human patient made of material allowing use of implant as visualization marker e.g. X-ray marker |
| 03/03/2005 | DE102004035803A1 Method for manufacturing water-soluble dispersed iron oxide nano-particles, useful as contrast agent, involves mixing solutions of iron, adding suitable amounts of organic acid and adjusting pH value |
| 03/03/2005 | CA2536359A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 03/02/2005 | EP1510225A2 Photochemotherapeutic and diagnostic application using 5-ALA and precursors |
| 03/02/2005 | EP1509617A2 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 03/02/2005 | EP1509254A1 New agents for magnetic imaging method |
| 03/02/2005 | EP1509246A2 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy |
| 03/02/2005 | EP1509202A1 Novel high viscosity embolizing compositions comprising prepolymers |
| 03/02/2005 | EP1179189B1 Process for the preparation of an mr contrast agent |
| 03/02/2005 | EP1169065B1 Methacoline or histamine formulations for detecting asthma |
| 03/02/2005 | EP1155023B1 Chelating compounds and their complexes with paramagnetic metals |
| 03/02/2005 | CN1589151A Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 03/01/2005 | US6862470 Cavity-filling biopsy site markers |
| 03/01/2005 | US6861442 PYK2 and inflammation |
| 03/01/2005 | US6861256 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 03/01/2005 | US6861045 Contrast-enhanced diagnostic imaging method for monitoring interventional therapies |
| 03/01/2005 | US6861043 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 03/01/2005 | US6860879 Use of 5-aminolevulinic acid or a derivate thereof for photodynamic diagnosis and/or photodynamic therapy |
| 02/24/2005 | WO2005017539A2 Imaging pathology |
| 02/24/2005 | WO2005017522A2 Method for in vivo determination on tested animals of the efficient concentration of deuterium depleted water for cancer therapy |
| 02/24/2005 | WO2005017189A2 Neural cell assay |
| 02/24/2005 | WO2005016401A2 Improved intra-dermal delivery of biologically active agents |
| 02/24/2005 | WO2005016387A2 Dna-dependent mri contrast agents |
| 02/24/2005 | WO2005016384A1 Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change |
| 02/24/2005 | WO2005016310A1 Novel metaxalone compositions |
| 02/24/2005 | WO2005016259A2 Polymersomes incorporating highly emissive probes |
| 02/24/2005 | WO2005016231A2 Agents and methods for treatment of disease by oligosaccharide targeting agents |
| 02/24/2005 | WO2005016198A1 Electrostatically charged nasal application product and method |
| 02/24/2005 | WO2005016141A1 Remote detection of substance delivery to cells |
| 02/24/2005 | WO2005016112A2 Post-biopsy cavity treatment implants and methods |
| 02/24/2005 | WO2005015988A1 Npc1l1 (npc3) and methods of use thereof |
| 02/24/2005 | WO2004093907A3 Therapeutic agents for treating dermatitis, alopecia and itching and transgenic animals for evaluating such therapeutic agents |
| 02/24/2005 | WO2004080335A3 Method for continuous visualization of a body lumen |
| 02/24/2005 | WO2004073656A3 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 02/24/2005 | WO2004032621A3 Techniques for identifying molecular structures and treating cell types lining a body lumen using fluorescence |
| 02/24/2005 | WO2004031725A3 Ratios of collagen peptides, their uses and products |
| 02/24/2005 | WO2004024088A3 Design of chemokine analogs for the treatment of human diseases |
| 02/24/2005 | WO2003037400A3 Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo |
| 02/24/2005 | US20050044581 Animals and cells containing a mutated alpha2/omega1 gene |
| 02/24/2005 | US20050044579 Neurotransmitter signaling can regulate life span in C. elegans |
| 02/24/2005 | US20050043518 Monoclonal antibody for use in detection of plant protein associated with natural rubber; diagnosing latex allergies and hypersensitivity |
| 02/24/2005 | US20050043377 Thioflavin derivatives for use in the antemortem diagnosis of alzheimers disease and in vivo imaging and prevention of amyloid deposition |
| 02/24/2005 | US20050043226 having a building unit containing one nitrogen atom of the peptide backbone connected to a bridging group comprising an amide, thioether, thioester, or disulfide; used to treat cancers, diabetes, diabetic-associated complications, endocrine disorders, gastrointestinal disorders, and pancreatitis |
| 02/24/2005 | US20050042738 Carbohydrate-associated proteins |
| 02/24/2005 | US20050042614 Point mutations; dipeptidyl-peptidase inhibitors; kits |
| 02/24/2005 | US20050042605 Using presence of long terminal repeat mutation in lymphadenopathy associated viral sequences as diagnostic indicator of viricidal drug resistance |
| 02/24/2005 | US20050042273 Covalently linking PDGF Nucleic Acid Ligand with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound to form a Complex; diagnostic and therapeutic agent; improving pharmacokinetic properties |
| 02/24/2005 | CA2535873A1 3h-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof |
| 02/24/2005 | CA2534924A1 Novel metaxalone compositions |
| 02/24/2005 | CA2533637A1 Polymersomes incorporating highly emissive probes |
| 02/24/2005 | CA2532576A1 Npc1l1 (npc3) and methods of use thereof |
| 02/24/2005 | CA2530224A1 Remote detection of substance delivery to cells |
| 02/24/2005 | CA2529697A1 Post-biopsy cavity treatment implants and methods |
| 02/24/2005 | CA2529048A1 Improved intra-dermal delivery of biologically active agents |
| 02/24/2005 | CA2525624A1 Method for in vivo determination on tested animals of the efficient concentration of deuterium depleted water for cancer therapy |
| 02/24/2005 | CA2497198A1 Agents and methods for treatment of disease by oligosaccharide targeting agents |
| 02/23/2005 | EP1507454A1 Animal model for toxicology and dose prediction |
| 02/23/2005 | EP1274710B1 Novel heteroaryl-diazabicycloalkanes |
| 02/23/2005 | EP0907380B1 Pressure resistant protein microspheres as ultrasonic imaging agents |
| 02/23/2005 | CN1582901A Preparation of gas containing lipid body and composite granule |
| 02/22/2005 | US6858705 Stable radioiodine conjugates and methods for their synthesis |
| 02/17/2005 | WO2005015215A1 Novel chemiluminescent compounds and their use |
| 02/17/2005 | WO2005015214A1 Novel chemiluminescent compounds and their use |
| 02/17/2005 | WO2005014051A1 Emulsion particles for imaging and therapy and methods of use thereof |
| 02/17/2005 | WO2005014042A1 HEART-SLOWING DRUG CONTAINING SHORT-ACTING β BLOCKER AS THE ACTIVE INGREDIENT |
| 02/17/2005 | WO2005013897A2 Magnetic nanoparticle compositions, and methods related thereto |
| 02/17/2005 | WO2005013810A2 Biodegradable embolic agents |
| 02/17/2005 | WO2005013682A2 Animal model for the analysis of tumor metastasis |
| 02/17/2005 | WO2004091592A3 Methods and compositions to treat myocardial conditions |
| 02/17/2005 | WO2004089072A8 Non-human mammals and animal cells containing a mutated alpha2/delta1 gene |
| 02/17/2005 | WO2004028338A3 A method to demonstrate the efficacy of pharmacological stress agent |
| 02/17/2005 | WO2003025131A3 Protein modification and maintenance molecules |
| 02/17/2005 | US20050039221 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 02/17/2005 | US20050038239 Locked nucleic acid conjugate for use in treatment of cell proliferative disorders |
| 02/17/2005 | US20050038234 Bi-functionalised metallocenes use for marking biological molecules |
| 02/17/2005 | US20050037974 E-Ca R Cb-A, in which E is a diagnostic agent, R is a reactive group, Cb and Ca are optional first and second connecting groups, and A is an affinity group that is any molecule or part of a molecule possessing specific binding determinants for a target molecule |
| 02/17/2005 | US20050037440 Methods of identifying longevity modulators and therapeutic methods of use thereof |
| 02/17/2005 | US20050037417 Screening peptide library for amino acid sequences which specifically target/hybridize to brain and kidney tissue; immunodiagnostics; tissue targeted therapy |
| 02/17/2005 | US20050037334 Method of determining sperm capacitation |
| 02/17/2005 | US20050037005 5c8 Antigen |
| 02/17/2005 | US20050036947 Target-specific activatable polymeric imaging agents |
| 02/17/2005 | US20050036946 Radio-opaque compounds, compositions containing same and methods of their synthesis and use |
| 02/17/2005 | US20050036945 Resorbable radiopaque markers and related medical implants |
| 02/17/2005 | US20050036943 Methods and compositions for the diagnosis of asthma |
| 02/17/2005 | CA2536659A1 Process |
| 02/17/2005 | CA2534687A1 Magnetic nanoparticle compositions, and methods related thereto |
| 02/17/2005 | CA2534426A1 Emulsion particles for imaging and therapy and methods of use thereof |
| 02/17/2005 | CA2531916A1 Animal model for the analysis of tumor metastasis |
| 02/16/2005 | EP1506784A1 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK |
| 02/16/2005 | EP1506774A1 Smooth muscle peristole inhibitor |
| 02/16/2005 | EP1506027A1 Cell delivery fluid for prevention of cell settling in delivery system |
| 02/16/2005 | EP1506022A2 Medium for contrast enhancement use for ultrasonic, endoscopic, and other medical examinations |
| 02/16/2005 | EP1505904A1 Method and apparatus for quantitatively evaluating a kidney |